CBP/p300-IN-20
CBP/p300-IN-20 is a potent and selective p300/CBP inhibitor, with a pIC50 of 10.1 for p300. CBP/p300-IN-20 can be used for the research of cancer[1].
Product Specifications
CAS Number
[2999742-92-4]
UNSPSC
12352005
Target
Epigenetic Reader Domain; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbp-p300-in-20.html
Purity
98.03
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1N(C(C2(CC(F)(F)C2)C3=CC=C(Cl)C=C3)=O)C[C@H](F)C1)NC4=CC=C5NN=CC5=N4
Molecular Formula
C22H19ClF3N5O2
Molecular Weight
477.87
References & Citations
[1]Tian X, et, al. Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening. J Med Chem. 2022 Nov 10;65 (21) :14391-14408.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CBP/p300
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL701344V 500 µL Each
Wnt7b Rat shRNA Lentiviral Particle (Locus ID 315196)
Sign In for Pricing
View Details